Efficacy and safety of rezafungin in critically ill patients with candidaemia and/or IC: Outcomes of patients treated in the ICU from an integrated analysis of Phase 2 and Phase 3 trials

P. M. Honore, M. Kollef, G. R. Thompson III,A. Soriano,O. A. Cornely, C. Dignani, N. Manamley, T. Sandison, P. G. Pappas, M. Bassetti

JAC-ANTIMICROBIAL RESISTANCE（2024）

引用 0|浏览1